Difference between revisions of "DZI19-121-Case-5"

From MGH Learn Pathology
(Automatic edit to upgrade to new templates)
(Updating subject, access, and performer)
Line 22: Line 22:
 
MGMT promoter: unmethylated (methylation specific PCR)
 
MGMT promoter: unmethylated (methylation specific PCR)
 
|reasonCode=38 y.o. woman with a 2 month hx of positional vertigo, L facial weakness, tinnitus, and left anterior tongue numbness
 
|reasonCode=38 y.o. woman with a 2 month hx of positional vertigo, L facial weakness, tinnitus, and left anterior tongue numbness
|subject=public
+
|subject=MGH
|performer=Mml55
+
|performer=MML55
 
|authoredOn=September 11, 2019 01:58:00 PM
 
|authoredOn=September 11, 2019 01:58:00 PM
 
|requester=Em99
 
|requester=Em99
 
|sequence=5
 
|sequence=5
 +
|access=public
 
}}
 
}}
 
{{Media
 
{{Media

Revision as of 15:09, June 21, 2022

DZI19-121-Case-5
38 y.o. woman with a 2 month hx of positional vertigo, L facial weakness, tinnitus, and left anterior tongue numbness
Integrated diagnosis:

DIFFUSE MIDLINE GLIOMA, H3K27M-MUTANT

Histological diagnosis: Anaplastic astrocytoma

WHO (integrated histological and molecular) grade: IV

Molecular information: H3K27M: MUTANT (immunohistochemistry) IDH: wildtype (IDH1/2 PCR sequencing) P53: negative in tumor cells (immunohistochemistry, consistent with wildtype) ATRX: nuclear expression retained (immunohistochemistry, consistent with wildtype)

MGMT promoter: unmethylated (methylation specific PCR)
December 31, 1969 7:00:00 PM